AHR and liver dysplastic nodule: Recent studies have indicated that AhR activation by the accumulation of uremic toxins may be implicated in various kidney diseases, including chronic kidney disease (CKD), CKD-associated complications, diabetic nephropathy (DN), acute kidney injury (AKI) and systemic lupus erythematosus (SLE) [8, 9].